CHM.CN jumps 900% to C$0.05 Waverunner (CNQ) 09 Mar 2026: Monitor volume

CHM.CN stock moved sharply in market hours on 09 Mar 2026, rising to C$0.05, a 900.00% intraday lift from yesterday’s close. The jump pushed Waverunner Capital Inc. (CHM.CN) on CNQ into high-volume mover screens as traders tested liquidity. This note breaks down the trading flow, valuation signals, and what catalysts traders should watch while keeping risk front of mind.

Trading snapshot and volume context for CHM.CN stock

CHM.CN stock opened the session after a prior close of C$0.005 and printed C$0.05, with a reported change of C$0.045. One figure to watch is average volume of 28,908.00 shares versus the spike today. This gap suggests a short-term liquidity event rather than steady institutional accumulation.

High relative moves like this often compress spreads and increase volatility. Traders should note shares outstanding of 744,233,000.00 and a market capitalisation of C$37,211,650.00, which magnifies price moves on modest share flows.

Fundamentals and valuation signals for CHM.CN stock

On fundamentals, Waverunner Capital reports EPS of -0.01 and a trailing P/E near -5.00, reflecting recent losses. Price averages sit at C$0.04 (50-day) and C$0.05 (200-day), with a year high of C$0.10 and year low of C$0.05. These metrics point to a microcap profile with thin liquidity and negative earnings.

Key ratios show current ratio 0.10 and cash per share C$0.01, which flag balance-sheet tightness versus healthcare sector peers (sector average current ratio ~1.90). Valuation here is driven more by event flow than fundamentals.

Meyka Grade and CHM.CN stock technical valuation

Meyka AI rates CHM.CN with a score out of 100: 64.96 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Technically, CHM.CN’s breakout above short-term averages signals momentum, but narrow trading range and limited free float can reverse quickly. Traders should use tight risk control and watch for follow-through volume above the 50-day average.

Catalysts, newsflow and CHM.CN stock trading drivers

Waverunner’s strategy as a venture investor and the June 2024 name change from Chemistree to Waverunner add periodic re-rating risk. Material catalysts include funding updates, PIPEs or asset sales, and sector news around health and biotech investment appetite. Newsflow can move CHM.CN stock abruptly because of thin liquidity.

Monitor company filings and investor updates on the Waverunner website and regulatory channels. Unexpected financing or portfolio exits are the most likely immediate triggers for price moves.

Risk profile and sector comparison for CHM.CN stock

CHM.CN sits in Healthcare, Drug Manufacturers – Specialty & Generic, where the sector shows negative recent performance and high dispersion. Sector average P/E is roughly 13.95 while CHM.CN’s negative earnings and high debt metrics increase downside risk. Small-cap venture portfolios typically show higher operational and liquidity risk.

Risk management should prioritise position sizing, stop-loss discipline, and monitoring of cash and liquidity announcements.

Short-term trading strategy and CHM.CN stock outlook

For high-volume movers, a trade plan is essential. Consider a short-term scalp if volume sustains above the 50-day average with strict stops below C$0.04. For swing traders, waiting for confirmation above C$0.06 with improving cash metrics reduces false-breakout risk.

Longer-term investors should demand clear portfolio exits or recurring cash flow before adding exposure given current fundamentals.

Final Thoughts

CHM.CN stock’s jump to C$0.05 on 09 Mar 2026 is a high-volume price event that requires active monitoring. Short-term momentum is clear, but fundamentals remain weak: EPS -0.01, negative P/E, low current ratio, and modest cash per share. Meyka AI’s forecast model projects a near-term reference level of C$0.07 (implied upside +40.00% versus the current C$0.05) and a 12-month scenario target of C$0.12 (implied upside +140.00%). Forecasts are model-based projections and not guarantees. Given the firm’s microcap structure, limited liquidity and event-driven profile, traders should prioritise position sizing, monitor filings, and use stop-loss orders. Meyka AI — the AI-powered market analysis platform — highlights that CHM.CN’s movement is driven by flows and catalysts rather than recurring earnings, so any investment stance should tie to specific company news or financing clarity.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.